Charles River-backed BioMotiv bears fruit with first biotech
BioMotiv and BMS signed an unusual drug development agreement, which has culminated in the launch of Anteros Pharmaceuticals.
Archives for February 5, 2020
Aridis’ cell line ‘halves’ mAb manufacturing time
Aiming to facilitate and accelerate discovery of biologics, Aridis’ Apex platform can also discover antibodies against viruses ‘within one day of a pandemic’.
Introducing digital connectivity to home infusions
Avoset works to develop infusion pump devices with embedded touch screens, able to connect to and be watched over via smart devices.
In-vitro models reduce ‘risk and cost’ for topically-delivered generics
Developers of generic drugs administered with topical drug delivery methods benefit from MedPharm’s in-vitro models to safely demonstrate bioequivalence.
Patient confidence key in switching delivery of biosimilars
As developers of biosimilars look at ways of differentiating from originator products, experts warn that patients will need to be brought on board.
RaniPill passes Phase I test for orally delivered biologics
Rani Therapeutics releases positive results from a Phase I clinical study into delivering octreotide by RaniPill.